After coronary artery bypass grafting, can I discontinue lisinopril and metoprolol since my heart rate is 79 bpm and blood pressure is 112/78 mm Hg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Discontinue These Medications Post-CABG

You should continue both lisinopril and metoprolol after CABG regardless of your current blood pressure and heart rate readings. Your vital signs being well-controlled (BP 112/78, HR 79) actually demonstrate that these medications are working effectively, not that they should be stopped.

Why Continue Metoprolol (Beta-Blocker)

Metoprolol must be continued indefinitely after CABG, and abrupt discontinuation is dangerous. The FDA explicitly warns that stopping metoprolol abruptly in patients with coronary artery disease can cause severe exacerbation of angina, myocardial infarction, and ventricular arrhythmias 1. When discontinuation is necessary, it must be tapered gradually over 1-2 weeks with careful monitoring 1.

The 2018 ESC/EACTS guidelines give a Class I recommendation for perioperative beta-blocker therapy to prevent post-operative atrial fibrillation after CABG 2. The 2011 ACCF/AHA guidelines similarly recommend continuing beta-blockers postoperatively in patients who were receiving them preoperatively 3.

Important Caveat on Long-Term Beta-Blocker Benefits

While beta-blockers are essential in the perioperative period and should not be abruptly stopped, the evidence for long-term mortality benefit after CABG is actually weak. A large Swedish registry study (n=28,812) found no association between beta-blocker use and mortality risk after CABG (HR 0.97,95% CI 0.90-1.06; p=0.54) 4. The IMAGINE trial post-hoc analysis showed beta-blockers were not associated with reductions in cardiovascular events or angina in stable, low-risk post-CABG patients 5. The MACB study similarly found no reduction in death or cardiac events over 2 years 6.

However, the critical point is that you cannot simply stop metoprolol because of the rebound risk. If discontinuation is ever considered in the future, it requires physician supervision with gradual tapering.

Why Continue Lisinopril (ACE Inhibitor)

ACE inhibitors should be reinstituted and continued indefinitely after CABG once you are stable. The 2011 ACCF/AHA guidelines provide Class I recommendations for this 3:

  • Class I (Level A): ACE inhibitors should be initiated postoperatively and continued indefinitely in CABG patients with LVEF ≤40%, hypertension, diabetes mellitus, or chronic kidney disease 3
  • Class I (Level B): ACE inhibitors given before CABG should be reinstituted postoperatively once the patient is stable 3
  • Class IIa (Level B): It is reasonable to continue ACE inhibitors indefinitely even in low-risk patients with normal LVEF 3

The Swedish registry study found that RAAS inhibitors (including ACE inhibitors like lisinopril) were associated with significantly lower mortality risk after CABG (HR 0.78,95% CI 0.73-0.84; p<0.001) 4.

Your Blood Pressure is Optimal, Not Too Low

Your BP of 112/78 mmHg is well-controlled and appropriate for a post-CABG patient. This is not hypotension—the guidelines specifically state that ACE inhibitors should not be instituted if systolic BP is <100 mmHg 3. Your reading is well above this threshold.

The Bottom Line

Both medications provide cardiovascular protection and should be continued indefinitely after CABG. Your well-controlled vital signs indicate therapeutic success, not a reason to discontinue. The combination of an ACE inhibitor and beta-blocker addresses different mechanisms of cardiovascular protection:

  • Lisinopril: Reduces mortality and provides cardiovascular protection, especially important given your coronary artery disease 4
  • Metoprolol: Cannot be safely discontinued abruptly due to rebound risk of MI and arrhythmias; provides rate control and prevents atrial fibrillation 1

Never discontinue these medications without physician guidance. Any future consideration of stopping metoprolol requires gradual tapering over 1-2 weeks under medical supervision 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.